About Blood

Blood is a weekly medical journal published by the American Society of Hematology. It was founded by Dr. William Dameshek, the researcher credited with describing the concept of myeloproliferative diseases and participating in the first studies of nitrogen mustard in various blood malignancies, in 1946, and has since been in continuous publication.

With 1,250 articles published annually, an impact factor of 10.896, and an Immediacy Index of 2.458,Blood is the most cited peer-reviewed publication in the field. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. All articles undergo a rigorous peer review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation. Blood is indexed and abstracted by Index Medicus, Excerpta Medica, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, SCISEARCH, Automatic Subject Citation Alert, ISI/BIOMED, and BIOSIS.

Blood Online provides access to First Edition Papers. These are pre-published papers that have been accepted into Blood, but are still going through our editorial process. First Edition Papers are fully integrated with the regular issues of Blood Online. They are searchable via Blood Online’s search engine, Cite Track, and Medline. First Edition Papers are also citable until the article is published in its final form.

Blood Online also provides a large amount of free content to the public. Five articles from each issue of Blood are made publicly available. Additionally, all articles are made publicly available twelve (12) months after publication. We also provide articles to patients free-of-charge (please visit our Public Access page for details).

The following special sections appear in issues of Blood:

  • Inside Blood – provides succinct summaries of cutting-edge topics, especially those that hold promise for future clinical application.
  • Plenary Papers – present cutting-edge findings in the broad discipline of hematology.
  • Review Articles – evaluate important advances in a wide range of specialty areas.

In addition to the fifty-two (52) weekly issues of Blood published annually, a supplemental issue is published in November of each year. This supplemental issue contains the ASH Annual Meeting Abstracts, and is published to coincide with the ASH Annual Meeting. The most recent four years of abstracts are searchable online via Blood Online’s search engine.

Disclaimer: The ideas and opinions expressed in Blood do not necessarily reflect those of the American Society of Hematology (ASH) or the Editors of Blood. Publication of an advertisement or other product mention in Blood should not be construed as an endorsement of the product or the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. ASH does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other health care professional, relying on his or her independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient

Similar Posts:

GD Star Rating
GD Star Rating

Leave a Comment